BioCentury
ARTICLE | Clinical News

FASgen preclinical data

January 17, 2005 8:00 AM UTC

In a mouse model of TB, FAS20013 was shown to be effective and gave no adverse side effects. The compound is 100% orally bioavailable. No dose limiting toxicity was observed even at doses 10 times hig...